Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
Twelve healthy young male subjects received either cefixime, a new oral cephalosporin (CL 284,635), or cefaclor (six subjects on each drug) orally for 2 weeks. In the case of cefixime, single daily doses of 400 mg were taken; with cefaclor, the dosage was 250 mg three times daily. Modest changes in...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1987
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174748/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3579262/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.3.443 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
